To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05955170
Title Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer (TUC-TOC)
Acronym TUC-TOC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Curie
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Jean Perrin SUSPENDED Clermont-Ferrand Clermont Ferrand 63011 France Details
CHU Amiens Picardie-Site Sud RECRUITING Amiens 80054 France Details
Institut Sainte Catherine RECRUITING Avignon 84000 France Details
Centre François Baclesse RECRUITING Caen 14076 France Details
Centre Georges-François Leclerc RECRUITING Dijon 21079 France Details
Centre Oscar Lambret RECRUITING Lille 59020 France Details
Institut Du Cancer Montpellier SUSPENDED Montpellier 34298 France Details
Hôpital Privé du Confluent RECRUITING Nantes 44277 France Details
Institut Curie RECRUITING Paris 75005 France Details
Hopital Saint-Louis Ap-Hp Senopole NOT_YET_RECRUITING Paris 75010 France Details
Centre CARIO-Hôpital Privé des Côtes d'Armor (HPCA) RECRUITING Plerin 22190 France Details
Institut Curie RECRUITING Saint Cloud 92210 France Details
Oncopole Claudius Regaud SUSPENDED Toulouse 31059 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field